Zentalis Pharmaceuticals, Inc. ZNTL

Set alert

Price alert · ZNTL

All alert types
1.96 USD -0.03 -1.51%

At close · Oct 30

1.96 0.00 -0.02%

After hours · Oct 30, 5:32 PM ET

Bid
1.95 × 2
Ask
1.96 × 2
1.86 Day range 1.99
1.28 52-week range 6.61
YTD
+45.19%
1 year
+31.54%
Open
1.99
Prev close
1.99
Mkt cap
192.32M
Vol
1.33M
Avg vol
1.21M
EPS
-1.96
P/E
0.00
Div yield
0.00%
More statistics
Low
1.86
High
1.99
Forward P/E
-0.89
Beta
1.74
Short ratio
3.17
Inst. own
98.01%
Dividend
0.00
Ex-div date
Earnings
Aug 9, 2024
50-d avg
3.31
200-d avg
6.71
1y target
9.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ZNTL has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-8.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 3

Valuation

P/E -0.7×
FY 2018: -19.8×FY 2019: -18.0×FY 2020: -18.1×FY 2021: -22.6×FY 2022: -4.5×FY 2023: -3.4×FY 2024: -1.3×FY 2025: -0.7×
FY 2018 5y median -3.4× FY 2025
P/S 0.0×
FY 2018: 29925×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 3.2×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.4×
FY 2018: 16.9×FY 2019: 13.5×FY 2020: 6.9×FY 2021: 9.9×FY 2022: 2.5×FY 2023: 2.3×FY 2024: 0.6×FY 2025: 0.4×
FY 2018 5y median 2.3× FY 2025
P/FCF -0.8×
FY 2018: -17.1×FY 2019: -21.1×FY 2020: -24.3×FY 2021: -22.4×FY 2022: -6.4×FY 2023: -4.8×FY 2024: -1.3×FY 2025: -0.8×
FY 2018 5y median -4.8× FY 2025
EV/EBITDA -0.7×
FY 2018: -16.6×FY 2019: -16.4×FY 2020: -17.5×FY 2021: -17.3×FY 2022: -4.6×FY 2023: -4.1×FY 2024: -1.2×FY 2025: -0.7×
FY 2018 5y median -4.1× FY 2025
EV/Sales 0.0×
FY 2018: 28128×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 3.3×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -129.1%
FY 2018: -5.8%FY 2019: -4.7%FY 2020: -4.1%FY 2021: -4.5%FY 2022: -15.6%FY 2023: -21.0%FY 2024: -79.4%FY 2025: -129.1%
FY 2018 5y median -21.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: -169878.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -283.6%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: -150478.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -246.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -63.4%
FY 2018: -85.1%FY 2019: -74.1%FY 2020: -38.2%FY 2021: -43.6%FY 2022: -54.6%FY 2023: -66.8%FY 2024: -49.2%FY 2025: -63.4%
FY 2018 5y median -54.6% FY 2025
ROIC -59.6%
FY 2018: -68.4%FY 2019: -63.2%FY 2020: -35.2%FY 2021: -50.3%FY 2022: -45.5%FY 2023: -60.3%FY 2024: -50.2%FY 2025: -59.6%
FY 2018 5y median -50.3% FY 2025
ROA -47.4%
FY 2018: -51.4%FY 2019: -51.8%FY 2020: -32.2%FY 2021: -33.6%FY 2022: -42.8%FY 2023: -52.0%FY 2024: -38.5%FY 2025: -47.4%
FY 2018 5y median -42.8% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2018: 0.0%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -100.0%
FY 2018 FY 2025
Operating Income 20.1%
FY 2018: 0.0%FY 2019: -97.0%FY 2020: -153.6%FY 2021: -82.3%FY 2022: -5.0%FY 2023: -31.8%FY 2024: 36.2%FY 2025: 20.1%
FY 2018 FY 2025
EPS (diluted) 18.0%
FY 2018: 0.0%FY 2019: -10.3%FY 2020: -122.5%FY 2021: -29.6%FY 2022: -20.4%FY 2023: 0.2%FY 2024: 47.9%FY 2025: 18.0%
FY 2018 FY 2025
Free Cash Flow 26.8%
FY 2018: 0.0%FY 2019: -61.3%FY 2020: -121.8%FY 2021: -82.9%FY 2022: -3.8%FY 2023: -25.3%FY 2024: 17.9%FY 2025: 26.8%
FY 2018 FY 2025

Financial Health

Current Ratio 6.9×
FY 2018: 4.3×FY 2019: 4.6×FY 2020: 12.1×FY 2021: 8.0×FY 2022: 8.0×FY 2023: 7.2×FY 2024: 7.3×FY 2025: 6.9×
FY 2018 5y median 7.3× FY 2025
Quick Ratio 6.9×
FY 2018: 4.3×FY 2019: 4.6×FY 2020: 12.1×FY 2021: 8.0×FY 2022: 8.0×FY 2023: 7.2×FY 2024: 7.3×FY 2025: 6.9×
FY 2018 5y median 7.3× FY 2025
Debt / Equity 0.2×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA -0.0×
FY 2018: 1.1×FY 2019: 1.4×FY 2020: 0.4×FY 2021: 0.1×FY 2022: -0.0×FY 2023: -0.1×FY 2024: -0.0×FY 2025: -0.0×
FY 2018 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -88.3×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31